Opzelura (ruxolitinib cream) - Incyte
Topical Ruxolitinib in Acute Skin GVHD (Graft Versus Host Disease) (clinicaltrials.gov) - Sep 4, 2026 - P1 | N=10 | Not yet recruiting | Sponsor: Children's Hospital Medical Center, Cincinnati 
New P1 trial • Graft versus Host Disease • Immunology
http://clinicaltrials.gov/ct2/show/NCT07801248
 
Sep 4, 2026
 
Prev Next